Metraipolis › archive › dc_0845ea367865

Is there an impact of autoimmune rheumatological diseases on cutaneous toxicity in breast cancer adjuvant radiotherapy? A mono-institutional experience — Europe PMC PMID:41083653

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41083653
DOI
10.1007/s12282-[numero omesso]-7
License (as archived)
solo-consultazione
Archived
2026-11-09T09:30:01.098Z
SHA-256 of the archived text
18f07f32d09917023604da921c88d0efa41c52dc676e333c43b7c96e3541fb9a
Stable URL of this page
https://metraipolis.com/documento/dc_0845ea367865

How to cite

Is there an impact of autoimmune rheumatological diseases on cutaneous toxicity in breast cancer adjuvant radiotherapy? A mono-institutional experience — Europe PMC PMID:41083653 — Europe PMC (en), https://europepmc.org/article/MED/41083653 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0845ea367865 (Metraipolis archive dc_0845ea367865, sha256 18f07f32d09917023604da921c88d0efa41c52dc676e333c43b7c96e3541fb9a)
BibTeX
@misc{dc0845ea367865,
  title = {Is there an impact of autoimmune rheumatological diseases on cutaneous toxicity in breast cancer adjuvant radiotherapy? A mono-institutional experience — Europe PMC PMID:41083653},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41083653},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0845ea367865; sha256 18f07f32d09917023604da921c88d0efa41c52dc676e333c43b7c96e3541fb9a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41083653. Agents can read the archived copy with the MCP tool read_document.